820 results on '"Serody, Jonathan S."'
Search Results
2. Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
3. Acetyl-CoA carboxylase obstructs CD8+ T cell lipid utilization in the tumor microenvironment
4. Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study
5. FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression
6. Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy
7. Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity
8. Minimal PD-1 expression in mouse and human NK cells under diverse conditions
9. Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality
10. Targeting PI3Kδ function for amelioration of murine chronic graft-versus-host disease
11. Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality
12. BET-bromodomain and EZH2 inhibitor–treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes
13. The Immune Landscape of Cancer
14. Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy
15. Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD
16. Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responses
17. Protein-based immune profiles of basal-like vs. luminal breast cancers
18. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality
19. Targeted therapy of human leukemia xenografts in immunodeficient zebrafish
20. Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD
21. Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
22. Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+lymphoma: a phase 1 study
23. Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas
24. Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD
25. A critical role for donor-derived IL-22 in cutaneous chronic GVHD
26. The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease
27. Alternative tumour-specific antigens
28. An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD
29. Author Correction: Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
30. Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by the Proteasome Inhibitor Bortezomib
31. Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
32. Data from Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
33. Supplementary Figures and Tables from Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes
34. Data from Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes
35. Supplemental Data File 1 from Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes
36. Supplementary Methods from Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
37. Supplementary Tables 10 - 14 from Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers
38. Supplementary Tables 4 - 9 from Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers
39. Data from Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers
40. Data from C-C Chemokine Receptor 5 on Pulmonary Mesenchymal Cells Promotes Experimental Metastasis via the Induction of Erythroid Differentiation Regulator 1
41. Supplementary Tables 1 - 3 from Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers
42. Supplementary Tables 15 - 25 from Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers
43. Figures S1 - S6 from Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers
44. Supplementary Tables 1 - 4, Figures 1 - 2 from Peptide/MHC Tetramer–Based Sorting of CD8+ T Cells to a Leukemia Antigen Yields Clonotypes Drawn Nonspecifically from an Underlying Restricted Repertoire
45. Data from Peptide/MHC Tetramer–Based Sorting of CD8+ T Cells to a Leukemia Antigen Yields Clonotypes Drawn Nonspecifically from an Underlying Restricted Repertoire
46. Supplementary Procedures and Supplementary Figures 1 through 3 from C-C Chemokine Receptor 5 on Pulmonary Mesenchymal Cells Promotes Experimental Metastasis via the Induction of Erythroid Differentiation Regulator 1
47. T-cell expression of AhR inhibits the maintenance of pTreg cells in the gastrointestinal tract in acute GVHD
48. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape
49. Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production
50. Targeting the Canonical Nuclear Factor-κB Pathway with a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.